Abluminus DES: Sirolimus Drug Eluting Coronary Stent
Abluminus DES+ - Concept Medical - Developing technologies for drug delivery with a strong emphasis on intellectual property.
REVOLUTIONARY DES TO ADDRESS
UNMET CLINICAL NEED

ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease.

ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction.

Sirolimus Eluting

Stent System

Abluminus DES+

Envisolution Technology

  • ABLUMINAL COATING - Abluminus DES+

    ABLUMINAL COATING

    Facilitate mono directional drug release and less systemic exposure of drug leading to faster re-endothelistation

  • FUSION COATING - Abluminus DES+

    FUSION COATING

    Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis

  • Edge Coating - Abluminus DES+

    Edge Coating

    The additional 0.5mm coating on the edge of the balloon which addresses the edge restenosis

  • Biodegradable Film - Abluminus DES+

    Biodegradable Film

    The formation of circular film with biodegradable polymer facilitate maximum drug delivery in blood wet conditions

TECHNICAL SPECIFICATION

Drug Polymer
DrugSirolimus
Drug Dose1.40µg/mm²
Drug CarrierCustomized biodegradable polymer matrix
Stent
Stent MaterialCobalt Chromium Alloy L605
Strut Thickness73µm
Strut Width80µm (hinge) – 120µm (strut)
Average RecoilLess than 5%
Average ForeshorteningLess than 1% (Zero foreshortening design)
Delivery System
Delivery SystemRX stent delivery system
Nominal Pressure8 bar
Rated Burst Pressure14 bar
Guide Wire Compatibility (max.)0.014″
Guiding Catheter Compatibility5F
Stent Diameter (mm)2.25, 2.50, 2.75, 3.00, 3.50, 4.00, 4.50, 5.00
Stent Length(mm)8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52
Crossing Profile0.038″
Entry Profile0.016″

ORDERING INFORMATION

Stent
Diameter
Stent Length
08 mm12 mm16 mm20 mm24 mm28 mm32 mm36 mm40 mm44 mm48 mm52 mm
2.25mmEAN22508EAN22512EAN22516EAN22520EAN22524EAN22528EAN22532EAN22536EAN22540
2.50mmEAN25008EAN25012EAN25016EAN25020EAN25024EAN25028EAN25032EAN25036EAN25040EAN25044EAN25048EAN25052
2.75mmEAN27508EAN27512EAN27516EAN27520EAN27524EAN27528EAN27532EAN27536EAN27540
3.00mmEAN30008EAN30012EAN30016EAN30020EAN30024EAN30028EAN30032EAN30036EAN30040EAN30044EAN30048EAN30052
3.50mmEAN35008EAN35012EAN35016EAN35020EAN35024EAN35028EAN35032EAN35036EAN35040EAN35044EAN35048EAN35052
4.00mmEAN40008EAN40012EAN40016EAN40020EAN40024EAN40028EAN40032EAN40036EAN40040EAN40044EAN40048EAN40052
4.50mmEAN45008EAN45012EAN45016EAN45020
5.50mmEAN50008EAN50012EAN45016EAN50020

 

Talk to a representative
Fill out a quick form and our representatives will be in touch.


Abluminus DES+

Clinical Programs

Sr. NoStudy NameType of StudyTarget PatientsCountryClinical Trials Identifier
Sr. No:  1Study Name:   ABILITY DIABETES GLOBAL Type of Study:  Prospective, multicenter, multinational, randomized, 2-arm parallel groupsTarget Patients:  3050Country:  South America, Asia, EuropeClinical Trials Identifier:  https://www.clinicaltrials.gov/ct2/show/NCT04236609
Sr. No:  2Study Name:   Ability RCT Type of Study:  Multi-centre, Single-blinded, Randomized, Investigator-initiated pilot clinical studyTarget Patients:  150Country:  ItalyClinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT03399994
Sr. No:  3Study Name:   en-ABL 1 Study Type of Study:  Prospective, Single centre, Non- randomized clinical trialTarget Patients:  40Country:  IndiaClinical Trials Identifier:  
Sr. No:  4Study Name:   Dedicate Registry Type of Study:  Prospective, Multi-center, Spontaneous clinical registryTarget Patients:  3,000Country:  EU And AsiaClinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT03509532
Sr. No:  5Study Name:   en-ABL e-REGISTRY Type of Study:  Multi-center, Prospective, All-comers registryTarget Patients:  2,500Country:  IndiaClinical Trials Identifier:  
Sr. No:  6Study Name:   CUT-DRESS RCT Type of Study:  Target Patients:  96Country:  Clinical Trials Identifier:  
Sr. No:  7Study Name:   CUT-DRESS Registry Type of Study:  Target Patients:  608Country:  Clinical Trials Identifier:  
“Confidence Through Evidence’”
Get in Touch